245 related articles for article (PubMed ID: 22631611)
1. Combined portal vein embolization and preoperative chemotherapy prior to liver resection for colorectal cancer metastases.
Spelt L; Norman P; Törnqvist L; Tingstedt B; Andersson R
Scand J Gastroenterol; 2012 Sep; 47(8-9):975-83. PubMed ID: 22631611
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy.
Fischer C; Melstrom LG; Arnaoutakis D; Jarnagin W; Brown K; D'Angelica M; Covey A; DeMatteo R; Allen P; Kingham TP; Tuorto S; Kemeny N; Fong Y
JAMA Surg; 2013 Dec; 148(12):1103-8. PubMed ID: 24173207
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases.
Simoneau E; Alanazi R; Alshenaifi J; Molla N; Aljiffry M; Medkhali A; Boucher LM; Asselah J; Metrakos P; Hassanain M
J Surg Oncol; 2016 Mar; 113(4):449-55. PubMed ID: 26955907
[TBL] [Abstract][Full Text] [Related]
4. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557
[TBL] [Abstract][Full Text] [Related]
5. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
[TBL] [Abstract][Full Text] [Related]
6. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
[TBL] [Abstract][Full Text] [Related]
7. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases.
Simoneau E; Aljiffry M; Salman A; Abualhassan N; Cabrera T; Valenti D; El Baage A; Jamal M; Kavan P; Al-Abbad S; Chaudhury P; Hassanain M; Metrakos P
HPB (Oxford); 2012 Jul; 14(7):461-8. PubMed ID: 22672548
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases.
Zorzi D; Chun YS; Madoff DC; Abdalla EK; Vauthey JN
Ann Surg Oncol; 2008 Oct; 15(10):2765-72. PubMed ID: 18636296
[TBL] [Abstract][Full Text] [Related]
9. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases.
Spelt L; Sparrelid E; Isaksson B; Andersson RG; Sturesson C
HPB (Oxford); 2015 Jun; 17(6):529-35. PubMed ID: 25726854
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
[TBL] [Abstract][Full Text] [Related]
12. Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study.
Collin Y; Paré A; Belblidia A; Létourneau R; Plasse M; Dagenais M; Turcotte S; Martel G; Roy A; Lapointe R; Vandenbroucke-Menu F
Int J Surg; 2019 Jan; 61():42-47. PubMed ID: 30537548
[TBL] [Abstract][Full Text] [Related]
13. Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
Reddy SK; Morse MA; Hurwitz HI; Bendell JC; Gan TJ; Hill SE; Clary BM
J Am Coll Surg; 2008 Jan; 206(1):96-106. PubMed ID: 18155574
[TBL] [Abstract][Full Text] [Related]
14. Perioperative chemotherapy with or without bevacizumab in patients with metastatic colorectal cancer undergoing liver resection.
Constantinidou A; Cunningham D; Shurmahi F; Asghar U; Barbachano Y; Khan A; Mudan S; Rao S; Chau I
Clin Colorectal Cancer; 2013 Mar; 12(1):15-22. PubMed ID: 23021126
[TBL] [Abstract][Full Text] [Related]
15. Tumor progression after preoperative portal vein embolization.
Hoekstra LT; van Lienden KP; Doets A; Busch OR; Gouma DJ; van Gulik TM
Ann Surg; 2012 Nov; 256(5):812-7; discussion 817-8. PubMed ID: 23095626
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
[TBL] [Abstract][Full Text] [Related]
17. Right portal vein embolization before right hepatectomy for unilobar colorectal liver metastases reduces the intrahepatic recurrence rate.
Oussoultzoglou E; Bachellier P; Rosso E; Scurtu R; Lucescu I; Greget M; Jaeck D
Ann Surg; 2006 Jul; 244(1):71-9. PubMed ID: 16794391
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
[TBL] [Abstract][Full Text] [Related]
19. Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis.
Chaudhury P; Hassanain M; Bouganim N; Salman A; Kavan P; Metrakos P
HPB (Oxford); 2010 Feb; 12(1):37-42. PubMed ID: 20495643
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
